Forest Laboratories and the Allergy Asthma Study Institute are streamlining their systems by shifting to interoperable digital identities and digital signatures. We welcome them to the developing SAFE-BioPharma cyber-community, stated Mollie Shields-Uehling, cEO and president, SAFE-BioPharma Association.. Allergy Asthma Research Institute, Forest Labs sign up for SAFE-BioPharma In a move to improve efficiency by reducing paper within their respective functions, Forest Laboratories and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association.Secondary outcomes included the incidence of complicated malaria, the protection and efficacy of antimalarial therapy, and pharmacokinetic characteristics of lumefantrine.05. We subsequently observed an incidence of malaria in the NNRTI group that was greater than anticipated and revised the sample size to 150 individuals, who be followed for at least 6 months. The statistical analysis was performed according to the intention-to-treat principle, with the use of Stata software, version 11.